Delivery Order SPE2DB22D1017-SPE2DB24FG1XM

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,973.04 Firm Fixed Price Delivery Order covers the supply of Junel FE 1.5 mg-30 mcg tablets, with an ultimate completion date of March 31, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,285.66 firm fixed price delivery order contract is for the supply of the contraceptive drug Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,148.34 fixed-price delivery order is for the pharmaceutical product "JUNEL FE 1.5 MG-30 MCG TABLET 28S", with a period of performance through November 2023. Amerisourcebergen is a large pharmaceutical distributor and healthcare solutions provider that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,120.63 contract is for the delivery of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product. The contract has a period of performance through October 27, 2023 and is a firm-fixed price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,232.79 firm fixed-price delivery order is for the supply of pharmaceutical products, specifically JUNEL FE 1MG-20MCG 168 tablets. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,104.48 firm fixed price delivery order is for the supply of Junel FE 1 mg-20 mcg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award, valued at $1,192.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of the pharmaceutical product JUNEL FE 1 MG-20 MCG TABLET 28S. The contract has an ultimate completion date of May 20, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,010.47 firm-fixed-price delivery order covers the supply of the generic pharmaceutical product Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.12 firm fixed-price contract covers the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceuticals product, with a period of performance through June 20, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,313.85, is a delivery order for the pharmaceutical product "JUNEL FE 1.5 MG-30 MCG TABLET 28S". The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG1XM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.35 Firm Fixed Price delivery order is for the supply of JUNEL FE 1.5 MG-30 MCG Tablets 28s, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of July 25, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/17/25, 10:02 AM